EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Key Aspects in the Nutritional Management of Polycystic Liver Disease Patients

Saniya Khan iD, Simone Di Cola iD, Silvia Lai iD, Flaminia Ferri iD, Vincenzo Cardinale, Manuela Merli iD

Nutrients · 2025

DOI: 10.3390/nu17142380 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrients, 2025. Verfasst von Saniya Khan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational and Precision Medicine, Sapienza University of Rome, 00185 Rome, Italy. Hauptthemen laut MEDLINE: Liver Diseases, Cysts, Malnutrition. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union—Next Generation EU, Mission 4, Component 2, Project PNC 0000001 D3 4 Health, European Union—NextGenerationEU.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Polycystic liver disease (PLD) is a rare genetic disorder characterized by the development of >10 fluid-filled cysts in the liver. While PLD can occur in isolation, it is most commonly associated with autosomal dominant polycystic kidney disease, adding complexity to its management. PLD is often asymptomatic but can lead to hepatomegaly, causing symptoms such as abdominal distension, pain and discomfort, early satiety, gastroesophageal reflux, and malnutrition, ultimately affecting patients’ quality of life. Current treatment strategies, including pharmacological and interventional approaches, focus on reducing liver volume and alleviating symptoms. However, management remains largely symptomatic, as no definitive therapies exist to halt cyst progression. Liver transplantation is the only curative option for patients with severe, progressive disease and refractory complications. The EASL guidelines recognize that PLD-related symptoms, primarily due to hepatomegaly, can contribute to involuntary weight loss and recommend assessing symptomatic patients for malnutrition and sarcopenia. Although evidence suggests that patients with PLD may be at risk of malnutrition, original data on the quality and extent of nutritional alterations remain scarce. The potential influence of nutrition on disease progression, symptom burden, and overall well-being is also largely unexplored. Given these knowledge gaps, addressing nutritional challenges, such as early satiety, is essential for optimizing symptom management and maintaining overall nutritional status. This review outlines a possible pathophysiology of malnutrition, specific dietary considerations and recommendations, and weight management in patients with PLD. Additionally, dietary complexities in patients with concurrent renal involvement are discussed, offering a practical framework for clinicians and dietitians in managing this challenging condition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver DiseasesCystsMalnutritionHumansNutritional StatusQuality of LifeHepatomegaly

Stichwörter der Autor:innen

malnutritionnutritionpolycystic liver diseasequality of lifesarcopenia

Autor:innen und Institutionen

  • Department of Translational and Precision Medicine, Sapienza University of Rome, 00185 Rome, Italy.
  • Nephrology Unit, Department of Translational and Precision Medicine, Sapienza University of Rome, 00185 Rome, Italy.
  • Beth Israel Deaconess Medical Center, Division of Gastroenterology, Hepatology and Nutrition, Harvard Medical School, Boston, MA 02215, USA.

ORCID-Profile: Saniya Khan, Simone Di Cola, Silvia Lai, Flaminia Ferri, Manuela Merli

Förderung

  • European Union—Next Generation EU, Mission 4, Component 2
  • Project PNC 0000001 D3 4 Health
  • European Union—NextGenerationEU
  • Next Generation Europe Grant PE 6 FONDAZIONE HEAL ITALIA ‘Health Extended Alliance for Innovative Therapies, Advanced Lab-research and Integrated Approaches of…
  • Generation Europe Grant: Rome Technopole Flagship 4 (FP 4)—Development, innovation and certification of medical and non-medical devices for health
  • PRIN 2022

Zitieren

APA

Khan, S., Di Cola, S., Lai, S., Ferri, F., Cardinale, V., & Merli, M. (2025). Key Aspects in the Nutritional Management of Polycystic Liver Disease Patients. Nutrients. https://doi.org/10.3390/nu17142380

Vancouver

Khan S, Di Cola S, Lai S, Ferri F, Cardinale V, Merli M. Key Aspects in the Nutritional Management of Polycystic Liver Disease Patients. Nutrients. 2025. doi:10.3390/nu17142380

BibTeX
@article{Khan2025,
  author = {Khan, Saniya and Di Cola, Simone and Lai, Silvia and Ferri, Flaminia and Cardinale, Vincenzo and Merli, Manuela},
  title = {Key Aspects in the Nutritional Management of Polycystic Liver Disease Patients},
  journal = {Nutrients},
  year = {2025},
  doi = {10.3390/nu17142380}
}
Kostenlos starten →